Tacrine (Tetrahydroaminoacridine)

Photograph of Tacrine (Tetrahydroaminoacridine) under the microscope.

Tacrine (also known as Cognex) has been around for a number of years, however its ability to treat the symptoms of mild to moderate Alzheimer's disease has only recently been discovered. The drug will not cure Alzheimer's and it will not stop the disease from it's normal progression, however it has been shown to improve thinking ability in some patients who suffer from this terrible plague. One of the earliest chemical changes that occurs in the brain of Alzheimer's patients is the loss of acetylcholine, which acts as a chemical messenger. Tacrine slows the breakdown of acetylcholine thus improving the quality of life for Alzheimer's patients. The drug may cause liver problems, so blood tests must be conducted on a regular basis on patients using this drug. Side effects include blurred vision, confusion, shortness of breath, and weakness.

© 1995-2022 by Michael W. Davidson and The Florida State University. All Rights Reserved. No images, graphics, software, scripts, or applets may be reproduced or used in any manner without permission from the copyright holders. Use of this website means you agree to all of the Legal Terms and Conditions set forth by the owners.
This website is maintained by our
Graphics & Web Programming Team
in collaboration with Optical Microscopy at the
National High Magnetic Field Laboratory.
Last modification: Monday, Jul 02, 2018 at 04:22 PM
Access Count Since April 15, 1997: 39905